SURAKSHA Suraksha Diagnostic Q1 FY26 results (Apr–Jun 2025) and concall
Management summary
- Suraksha Diagnostic Limited reported a strong Q1 FY26 with an 18.83% YoY increase in total income to ₹73.49 crores and a 19.67% rise in PAT to ₹9.18 crores.
- The company expanded its network by 8 new centers, reaching 58, and strategically entered genomic medicine through the acquisition of Fetomat Wellness and the launch of Suraksha Genomics.
- While new center losses and a shift in B2B/B2C mix impacted revenue per test and diluted overall EBITDA margin to 33.97%, management expects margins to improve as newer centers mature and aims for 15-18 new centers this fiscal year.
Source: Inve concall analysis and management guidance record.
Highlights
-
Total income grew 18.83% YoY to ₹73.49 crores, demonstrating robust top-line growth.
-
EBITDA stood at ₹24.66 crores with a healthy margin of 33.97%.
-
PAT increased 19.67% YoY to ₹9.18 crores, reflecting strong bottom-line performance.
-
Expanded network by adding 8 new centers in Q1 FY26, bringing the total to 58 centers.
What they filed
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|---|---|---|
| Revenue | 59 | 64 | 70 |
| EBITDA | 18 | 20 | 24 |
| Net profit | 6 | 8 | 10 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Guidance & targets
2Network Expansion
New centers to be added Network Expansion · FY26 · High confidence 15-18 centers
Total centers Network Expansion · next 2-3 years · Medium confidence 100 centers
Source: Inve Guidance Tracker — management targets and direct quotes from the earnings call transcript.
Q&A highlights
2Diagnostic centers vs. hospitals in competitive landscape Direct
The second is the known diagnostic center happens to be at least 30% to 40% cheaper than the hospital diagnostics. So, these are the two main reasons that today the majority of the patients will always approach an independent diagnostic center rather than a hospital.
Explains the competitive advantage of independent diagnostic centers (cost and accessibility) over hospital diagnostics, which is crucial for Suraksha's business model.
Asked by Hitaindra Pradhan
Rental payment for the quarter Partial
So, it varies from, you know, totally other expenses when you see on my financials, which is 17% of my total revenue, which includes around 8% to 9% which is pertaining to rent.
Provides insight into a significant operating cost component (rent) as a percentage of revenue, helping analysts model expenses.
Asked by Hitaindra Pradhan
Unlock risks & concerns, Q2 FY26 watchlist, and full call analysis
You’re reading a preview. Opening the full call uses 1 concall credit and unlocks:
- 7 risks, concerns & management red flags
- 3 watchlist triggers for Q2 FY26
- +6 more guidance targets & verbatim management quotes
- +6 more analyst Q&A exchanges & evasion checks
- Capital allocation & full section-by-section narrative
Sign in to use your monthly call allowance.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared and our regulatory disclaimer. · Share on WhatsApp · Scorecard image





